News Articles for Barry Marshall

Tributes are flowing for Perth scientist Robin Warren, who was jointly awarded the Nobel Prize in Physiology or Medicine with colleague Barry Marshall in 2005.

The state's commercial health-related research and technology sector has matured.

There's no shortage of ideas for how WA can attract talent and new industries when the pandemic abates.

WA has many advantages in terms of hosting a thriving medical research and innovation ecosystem.

SPECIAL REPORT: Despite WA's history of innovative medical research, the state's medtech sector continues to grapple with outsider perceptions and its own commercial direction.

A Perth biotech company founded by Nobel Prize winner Barry Marshall has secured a promise of $1 million in federal funding for the commercialisation of its acoustic belt for gut monitoring.

Billions have been invested to ensure WA remains at the forefront of medical innovation and discovery.

The Noisy Guts Project and Chemo@home have taken home the respective Emerging Innovation and Growth categories at last nights Innovator of the Year awards, marking a big win for Perth-based healthcare and research.

Nominations are being sought for the 2016 Western Australian Science Hall of Fame, which recognises the outstanding work of the state's scientists.

Australia was named the 13th most innovative country in Bloomberg's Innovation Index 2015, but what will it take for Australia to climb to the number one position in the next 15 years?

The call is clear – government and angel investors need to do more to help startup businesses.

Western Australian Nobel prize winner Barry Marshall has called on the state government to kick-start a $100 million angel investment fund.

It's worth taking note when scientists buck-up against a Labor government.

Two companies established by academics with close links to the University of Western Australia are among the latest recipients of federal government research and development grants.

Despite some initial setbacks, Nobel Prize winner and medical research scientist Professor Barry Marshall is making inroads after some early setbacks with his spin-off company, Ondek Pty Ltd, which plans to licence an oral vaccine delivery system develope